Interní Med. 2011; 13(11): 445-449

Mycoses and antifungals

doc.MUDr.Petr Hamal, Ph.D., MDDr.Lucie Svobodová
Ústav mikrobiologie, LF UP a FN Olomouc

In the article, basic characteristics of mycoses and etiological agents’ specification are presented, with emphasis on infections frequently

occurring in medical practice. Proper sampling is crucial for determination or verification of clinically suspected fungal infections.

Guidelines for the collection of clinical specimen for mycological examination are described in detail. Further, an overview and brief

characterization of diagnostic methods currently used in mycology laboratories are given and their limits in terms of speed and reliability

are specified. Finally, a recent overview of registered antifungal drugs including their forms of administration is also presented and the

current status of antifungal susceptibility testing is briefly evaluated.

Keywords: mycoses, sampling, diagnostic methods, antifungal drugs

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hamal P, Svobodová L. Mycoses and antifungals. Interní Med. 2011;13(11):445-449.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Richardson MD, Warnock DW. Fungal infection. Blackwell Science Ltd. 1997. 249 s.
    2. Vosmík F, Skořepová M. Dermatomykózy. Praha: Galén 1995.
    3. Haber J, a kol. Systémové mykózy a jejich léčba. Praha: Galén 1995.
    4. Bartáková H, Cetkovský P, Drgoňa L, a kol. Invazivní aspergilóza: současné možnosti diagnostiky. Vnitř Lék 2007; 53(Suppl): 34 s.
    5. Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: Analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011; doi: 10.1111/j.1469-0691.2010.03456.x.
    6. Tomšíková A. Nebezpečí importovaných mykóz. Praha: Univerzita Karlova v Praze, 1998.
    7. Hamal P. Molekulárně genetické metody v lékařské mykologii: současný stav a perspektivy. Klin Mikrobiol inf Lék 2007; 13: 136-144.
    8. Hamal P. Možnosti a limity v diagnostice viscerálních mykóz. Zprav. klin. Farmakol. Farmac. 1997; 11: 33-36.
    9. Ráčil Z, Kocmanová I, Weinbergerová B, a kol. Terapie invazivních mykóz. Interní Med. 2008; 10: 167-171.
    10. Diamantová D. Léčba mykóz. Interní Med. 2003; 5: 8-10.
    11. Skořepová M. Současné možnosti terapie onychomykóz. Farmakoterapie 2007; 3: 249-252.
    12. Automatizovaný informační seznam léčivých přípravků. http://www.aislp.cz/cs/.
    13. Haber J, Čermák J, Indrák K, a kol. Stanovisko odborných společností k indikaci a použití antimykotik se systémovým účinkem. Klin Mikrobiol inf Lék 2003; 9: 294-300.
    14. CLSI. Reference method for broth dilution antifungal susceptibility testing for yeasts; third informational supplement. CLSI document M27-S3. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.